About

Company description

Syngene International Ltd. (BSE: 539268, NSE: SYNGENE, ISIN: INE398R01022), is an innovation focused global discovery, development and manufacturing organisation providing integrated scientific services to the pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical industries around the world. Syngene’s clientele include world leaders such as Bristol-Myers Squibb, Baxter, Amgen, GSK, Merck KGaA and Herbalife. Its innovative culture is driven by the passion of its 4000-strong team of scientists who work with clients from around the world to solve their scientific problems, improve R&D productivity, speed time to market and lower the cost of innovation. For more details, visit www.syngeneintl.com.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Central/South America
Affiliated categories: API Contract Manufacturing |Biopharmaceuticals (general category) |Clinical Research (Field) More

Upcoming events

5 may 2020

CPhI North America 2020

5 - 7 May 2020 Philadelphia, USA Visit us at stand 1231 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany We were at stand 121C63 See our Exhibitor Profile   See full Exhibitor List
18 jun 2019

CPhI & PMEC China 2019

18 - 20 June 2019 SNIEC, Shanghai, China We were at stand E8B17 See our Exhibitor Profile   See full Exhibitor List
30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 2243 See our Exhibitor Profile   See full Exhibitor List

News about Syngene International Ltd.

Syngene International Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services

3 Oct 2019

Syngene International Announces Partnership with Zumutor Biologics for Biotherapeutic Antibody Discovery Services

Syngene will screen target antigens against Zumutor’s proprietary human antibody libraries to identify and characterize novel antibody clones.

Read more

3 Oct 2019

Syngene International and BIRAC set up Centre for Advanced Protein Studies (CAPS)

CAPS will help address this challenge and will be a big boost in advancing biopharma research and product development in India.

Read more

3 Oct 2019

Syngene International wins CMO Leadership Awards presented by Life Science Leader Magazine

Syngene was successfully rated across the six categories - Capabilities, Compatibility, Expertise, Quality, Reliability and Service – that were used to gauge the eventual winner.

Read more

12 Sep 2018

Syngene International Expands Collaboration with Baxter

Syngene International Ltd., a leading global Contract Research Organization, announced the expansion of the scope of its R&D collaboration with Baxter Healthcare Corporation, a global healthcare company. As part of the expansion, Syngene will set up additional infrastructure at the dedicated Baxter Global Research Center (BGRC) as well as increase the size of its scientific team working on Baxter projects. The duration of the agreement has also...

Read more
Syngene International Ltd.

Contact information

Address

Telephone

Website

View all contact information